Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

A year after the first samRNA vaccine approval, experts say similar vaccines in development are likely to face scientific and ...

On Thursday, Moderna Inc (MRNA) stock saw a decline, ending the day at $52.8 which represents a decrease of $-0.59 or -1.11% from the prior close of $53.39. The stock opened at $53.39 and touched a ...

The discovery of the first mRNA-stabilizing substance could pave the way for groundbreaking advancements in the development ...

A new vaccine that could stop people from developing the vomiting bug norovirus is on trial in the UK. The mRNA vaccine from ...

However, the speed of vaccine production is limited because the mRNA used in it is partly chemically synthesized and partly ...

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.

Study reveals single-chain mRNA vaccines confer 100% protection against lethal mpox challenge in mice, marking a significant ...

Scientists in Australia have found why mRNA vaccines trigger side effects, paving the way for more effective vaccines.

With exclusive FDA insight, the 4th mRNA Analytical Development & Quality Control Summit returns; uniting the Analytical, ...